A major HIV vaccine trial is underway in five sites across South Africa. As the country and medical research community alike are coming to terms with the abrupt end of a microbicide candidate vaccine trial, Dr Busi Nkala, Director of the vaccine study at the Perinatal HIV Research Unit in Soweto, says the safety of patients is a key priority throughout the trial.